-
Gene Editing Research Project Granted $175K
Researchers at the University of California in Los Angeles (UCLA) have been awarded a $175,000 grant from Parent Project Muscular Dystrophy (PPMD) to make CRISPR/Cas9 as safe and effective as possible as a gene therapy tool to treat Duchenne muscular dystrophy (DMD).
According to the researchers, their planned CRISPR/Cas9 gene editing platform could be applicable to almost half of the people living with DMD because it deletes exons 45 to 55 of the dystrophin-producing (DMD) gene, where many of the mutations that cause the disease are found. Learn more about this research project here.
How do you feel about gene editing?
Sorry, there were no replies found.
Log in to reply.